Skip to content
healthcare.dev

Methotrexate

NDC 62135-772, Methotrexate, tablet, from Chartwell RX, LLC.

Product NDC
62135-772
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210454
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-772 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE SODIUM2.5 mg/1

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
62135-772-356213507723536 TABLET in 1 BOTTLE (62135-772-35)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2609da8f-80dc-448e-8eba-35d11488ce7f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=62135-772
  • NADAC price for package 62135077235

    GET /v1/drugs/nadac/62135077235

Use it

Look up 62135-772 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-772 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-772. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.